MedTrace Logo

Arrhythmic Risk in Myocarditis Outcome Research

NCT07501481 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-03-30

No results posted yet for this study

Summary

The goal of this observational, retrospective, multicenter study is to characterize the arrhythmic burden and identify predictive factors for ventricular arrhythmias (VAs) in adult patients hospitalized for acute myocarditis (AM). The main questions it aims to answer are:

* What is the incidence of sustained ventricular arrhythmias during the index hospitalization in patients with acute myocarditis?
* What clinical, biological, electrocardiographic, and imaging factors predict the occurrence of sustained ventricular arrhythmias during hospitalization and after discharge?

Researchers will compare patients who developed sustained VAs during hospitalization to those who did not, in order to identify independent predictors of arrhythmic events and develop a validated risk stratification score.

Participants' medical records from 2020 to 2024 will be reviewed to collect:

* Baseline demographic, clinical, biological, electrocardiographic, and imaging data at admission
* In-hospital management strategies and outcomes, including mortality, cardiogenic shock, and heart replacement therapy
* Long-term follow-up data including VA recurrence, sudden cardiac death, and development of cardiomyopathy, with censoring applied on January 1, 2026

Conditions

  • Myocarditis Acute
  • Ventricular Arrhythmia

Interventions

OTHER

Treatment of acute myocarditis

Standard medical and interventional management of acute myocarditis in accordance with local protocols

Sponsors & Collaborators

  • University Hospital, Toulouse

    collaborator OTHER

  • Rennes University Hospital

    collaborator OTHER

  • University Hospital, Montpellier

    collaborator OTHER

  • University Hospital, Bordeaux

    collaborator OTHER

  • Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

    collaborator OTHER

  • Poitiers University Hospital

    collaborator OTHER

  • AZ Sint-Jan AV

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-12-31
Completion
2027-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07501481 on ClinicalTrials.gov